Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company based in Los Angeles, California, focusing on the innovative research and development of therapeutic solutions for critical health challenges, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), and various types of cancer. With a commitment to advancing the biotechnology landscape, Renovaro aims to leverage its proprietary technologies to deliver novel pharmaceutical and biological products. As it progresses through its development pipeline, the company represents a unique investment opportunity in the evolving field of targeted disease management.
Click "Analyze" to generate stock analysis
RENB Price Trend and Signals
RENB Option Volumes & Open Interests (aggregated)
RENB Put Call Ratios and IV (aggregated)
RENB Financials
2025-09-30Bullishmacd_signal
Golden cross below zero detected.
2025-09-30Somewhat Bullishprice_signal
Half-yearly high detected.
2025-09-30Bullishprice_signal
Large price change detected: 992.31%.
2025-09-29Somewhat Bearishprice_signal
Yearly low detected.
2025-09-26Somewhat Bearishprice_signal
Yearly low detected.
2025-09-25Somewhat Bearishprice_signal
Yearly low detected.
2025-09-25Bearishprice_signal
Large price change detected: -17.65%.
2025-09-23Somewhat Bearishprice_signal
Yearly low detected.
2025-09-22Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-09-22Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-09-22Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-09-22Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-09-22Somewhat Bearishprice_signal
Yearly low detected.
2025-09-19Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.